Company: BNRG
Filing Date: 2025-08-04
Form Type: F-3
Source: 0001213900-25-071400
Chunk: 18

Company: Brenmiller Energy Ltd.
Filing Date: 2025-08-04
Form: F-3
Chunk 18
---
 the date set forth in the relevant footnote next to the selling shareholder’s name. The fourth column assumes the sale of
all of the Ordinary Shares offered by the selling shareholder pursuant to this prospectus.

In accordance with the terms
of the July 2025 Private Placement, this prospectus generally covers the resale of (i) 100% of the Ordinary Shares issued or issuable
upon exercise of the Pre-Funded Warrants issued pursuant to the terms of the Securities Purchase Agreement, (ii) the 200% of the Ordinary
Shares issued or issuable upon exercise of the Warrants. Because the number of Ordinary Shares may be adjusted for reverse and forward
share splits, share dividends, share combinations and other similar transactions, the number of Ordinary Shares that will actually be
issued may be more or less than the number of Ordinary Shares being offered by this prospectus.

The term “selling shareholder”
also includes any transferees, pledgees, donees, or other successors in interest to the selling shareholder named in the table below.
Unless otherwise indicated, to our knowledge, the selling shareholder named in the table below has sole voting and investment power (subject
to applicable community property laws) with respect to the Ordinary Shares set forth opposite its name. We will file a supplement to this
prospectus (or a post-effective amendment to the registration statement of which this prospectus forms a part, if necessary) to name successors
to the selling shareholder who is able to use this prospectus to resell the securities registered hereby.

The columns titled “Maximum Number of Shares
to be Sold Pursuant to this Prospectus” and “Shares Owned Immediately After Sale of Maximum Number of Shares in this Offering”
assume the sale of the Pre-Funded Warrants at an exercise price of $0.00001, and the Ordinary Warrants at an exercise price of $2.40.

Under the terms of the Warrants,
a selling stockholder may not exercise the Warrants to the extent such selling stockholder or any of its affiliates would beneficially
own a number of shares of our Ordinary Shares which would exceed 9.99% of our outstanding shares. Under the terms of the Pre-Funded Warrants,
a selling stockholder may not exercise the Pre-Funded Warrants to the extent such selling stockholder or any of its affiliates would beneficially
own a number of shares of our Ordinary Shares which would exceed 24.99% of our outstanding shares. The number of shares in the second
column reflects these limitations